$EPZM Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Epizyme, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Epizyme, Inc.. Get notifications about new insider transactions in Epizyme, Inc. for free.
Page: < prev 1 ... 2 3 4 5 6 7 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 18 2014 | EPZM | Epizyme, Inc. | KERINS PATRICK J | 10% Owner | Buy | J | 0.00 | 12,900 | 0 | 12,900 | 0 to 12.9 K |
| Aug 18 2014 | EPZM | Epizyme, Inc. | KERINS PATRICK J | 10% Owner | Sell | J | 0.00 | 1,290,000 | 0 | 4,743,240 | 6 M to 4.7 M (-21.38 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | KOLLURI KRISHNA KITTU | 10% Owner | Sell | S | 36.57 | 84 | 3,072 | 0 | 84 to 0 (-100.00 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | KOLLURI KRISHNA KITTU | 10% Owner | Buy | J | 0.00 | 84 | 0 | 84 | 0 to 84 |
| Aug 18 2014 | EPZM | Epizyme, Inc. | KOLLURI KRISHNA KITTU | 10% Owner | Sell | S | 36.57 | 84 | 3,072 | 0 | 84 to 0 (-100.00 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | KOLLURI KRISHNA KITTU | 10% Owner | Buy | J | 0.00 | 84 | 0 | 84 | 0 to 84 |
| Aug 18 2014 | EPZM | Epizyme, Inc. | KOLLURI KRISHNA KITTU | 10% Owner | Sell | S | 36.57 | 483 | 17,663 | 0 | 483 to 0 (-100.00 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | KOLLURI KRISHNA KITTU | 10% Owner | Buy | J | 0.00 | 483 | 0 | 483 | 0 to 483 |
| Aug 18 2014 | EPZM | Epizyme, Inc. | KOLLURI KRISHNA KITTU | 10% Owner | Sell | J | 0.00 | 12,900 | 0 | 0 | 12.9 K to 0 (-100.00 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | KOLLURI KRISHNA KITTU | 10% Owner | Buy | J | 0.00 | 12,900 | 0 | 12,900 | 0 to 12.9 K |
| Aug 18 2014 | EPZM | Epizyme, Inc. | KOLLURI KRISHNA KITTU | 10% Owner | Sell | J | 0.00 | 1,290,000 | 0 | 4,743,240 | 6 M to 4.7 M (-21.38 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | KOLLURI KRISHNA KITTU | 10% Owner | Sell | S | 36.57 | 84 | 3,072 | 0 | 84 to 0 (-100.00 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | KOLLURI KRISHNA KITTU | 10% Owner | Buy | J | 0.00 | 84 | 0 | 84 | 0 to 84 |
| Aug 18 2014 | EPZM | Epizyme, Inc. | KOLLURI KRISHNA KITTU | 10% Owner | Sell | S | 36.57 | 84 | 3,072 | 0 | 84 to 0 (-100.00 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | KOLLURI KRISHNA KITTU | 10% Owner | Buy | J | 0.00 | 84 | 0 | 84 | 0 to 84 |
| Aug 18 2014 | EPZM | Epizyme, Inc. | KOLLURI KRISHNA KITTU | 10% Owner | Sell | S | 36.57 | 483 | 17,663 | 0 | 483 to 0 (-100.00 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | KOLLURI KRISHNA KITTU | 10% Owner | Buy | J | 0.00 | 483 | 0 | 483 | 0 to 483 |
| Aug 18 2014 | EPZM | Epizyme, Inc. | KOLLURI KRISHNA KITTU | 10% Owner | Sell | J | 0.00 | 12,900 | 0 | 0 | 12.9 K to 0 (-100.00 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | KOLLURI KRISHNA KITTU | 10% Owner | Buy | J | 0.00 | 12,900 | 0 | 12,900 | 0 to 12.9 K |
| Aug 18 2014 | EPZM | Epizyme, Inc. | KOLLURI KRISHNA KITTU | 10% Owner | Sell | J | 0.00 | 1,290,000 | 0 | 4,743,240 | 6 M to 4.7 M (-21.38 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Buy | J | 0.00 | 651 | 0 | 651 | 0 to 651 |
| Aug 18 2014 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Sell | J | 0.00 | 12,900 | 0 | 0 | 12.9 K to 0 (-100.00 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Buy | J | 0.00 | 12,900 | 0 | 12,900 | 0 to 12.9 K |
| Aug 18 2014 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Sell | J | 0.00 | 1,290,000 | 0 | 4,743,240 | 6 M to 4.7 M (-21.38 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | SANDELL SCOTT D | 10% Owner | Sell | S | 36.94 | 384 | 14,185 | 0 | 384 to 0 (-100.00 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | SANDELL SCOTT D | 10% Owner | Sell | S | 36.45 | 3,027 | 110,334 | 384 | 3.4 K to 384 (-88.74 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | SANDELL SCOTT D | 10% Owner | Buy | J | 0.00 | 3,411 | 0 | 3,411 | 0 to 3.4 K |
| Aug 18 2014 | EPZM | Epizyme, Inc. | SANDELL SCOTT D | 10% Owner | Buy | J | 0.00 | 651 | 0 | 651 | 0 to 651 |
| Aug 18 2014 | EPZM | Epizyme, Inc. | SANDELL SCOTT D | 10% Owner | Sell | J | 0.00 | 12,900 | 0 | 0 | 12.9 K to 0 (-100.00 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | SANDELL SCOTT D | 10% Owner | Buy | J | 0.00 | 12,900 | 0 | 12,900 | 0 to 12.9 K |
| Aug 18 2014 | EPZM | Epizyme, Inc. | SANDELL SCOTT D | 10% Owner | Sell | J | 0.00 | 1,290,000 | 0 | 4,743,240 | 6 M to 4.7 M (-21.38 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | Viswanathan Ravi | 10% Owner | Sell | S | 35.56 | 433 | 15,396 | 0 | 433 to 0 (-100.00 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | Viswanathan Ravi | 10% Owner | Buy | J | 0.00 | 433 | 0 | 433 | 0 to 433 |
| Aug 18 2014 | EPZM | Epizyme, Inc. | Viswanathan Ravi | 10% Owner | Sell | J | 0.00 | 12,900 | 0 | 0 | 12.9 K to 0 (-100.00 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | Viswanathan Ravi | 10% Owner | Buy | J | 0.00 | 12,900 | 0 | 12,900 | 0 to 12.9 K |
| Aug 18 2014 | EPZM | Epizyme, Inc. | Viswanathan Ravi | 10% Owner | Sell | J | 0.00 | 1,290,000 | 0 | 4,743,240 | 6 M to 4.7 M (-21.38 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | Weller Harry R | 10% Owner | Buy | J | 0.00 | 439 | 0 | 439 | 0 to 439 |
| Aug 18 2014 | EPZM | Epizyme, Inc. | Weller Harry R | 10% Owner | Buy | J | 0.00 | 24 | 0 | 24 | 0 to 24 |
| Aug 18 2014 | EPZM | Epizyme, Inc. | Weller Harry R | 10% Owner | Buy | J | 0.00 | 24 | 0 | 24 | 0 to 24 |
| Aug 18 2014 | EPZM | Epizyme, Inc. | Weller Harry R | 10% Owner | Sell | J | 0.00 | 12,900 | 0 | 0 | 12.9 K to 0 (-100.00 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | Weller Harry R | 10% Owner | Buy | J | 0.00 | 12,900 | 0 | 12,900 | 0 to 12.9 K |
| Aug 18 2014 | EPZM | Epizyme, Inc. | Weller Harry R | 10% Owner | Sell | J | 0.00 | 1,290,000 | 0 | 4,743,240 | 6 M to 4.7 M (-21.38 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | NEA Partners 13, Limited Partn ... | 10% Owner | Sell | J | 0.00 | 12,900 | 0 | 0 | 12.9 K to 0 (-100.00 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | NEA Partners 13, Limited Partn ... | 10% Owner | Buy | J | 0.00 | 12,900 | 0 | 12,900 | 0 to 12.9 K |
| Aug 18 2014 | EPZM | Epizyme, Inc. | NEA Partners 13, Limited Partn ... | 10% Owner | Sell | J | 0.00 | 1,290,000 | 0 | 4,743,240 | 6 M to 4.7 M (-21.38 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | NEW ENTERPRISE ASSOCIATES 13 L ... | 10% Owner | Sell | J | 0.00 | 1,290,000 | 0 | 4,743,240 | 6 M to 4.7 M (-21.38 %) |
| Aug 05 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Option Exercise | M | 0.60 | 20,000 | 12,000 | 76,314 | |
| Aug 05 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Sell | S | 29.88 | 8,427 | 251,784 | 5,305 | 13.7 K to 5.3 K (-61.37 %) |
| Aug 05 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Sell | S | 29.08 | 11,573 | 336,563 | 13,732 | 25.3 K to 13.7 K (-45.73 %) |
| Aug 05 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Buy | M | 0.60 | 20,000 | 12,000 | 25,305 | 5.3 K to 25.3 K (+377.00 %) |
| Aug 05 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and ... | Option Exercise | M | 0.60 | 34,000 | 20,400 | 70,819 | |
| Aug 05 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and ... | Option Exercise | M | 3.54 | 8,000 | 28,320 | 194,833 | |
| Aug 05 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and ... | Sell | S | 30.05 | 18,400 | 552,898 | 82,000 | 100.4 K to 82 K (-18.33 %) |
| Aug 05 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and ... | Sell | S | 29.26 | 11,600 | 339,426 | 100,400 | 112 K to 100.4 K (-10.36 %) |
| Aug 05 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and ... | Buy | M | 0.60 | 34,000 | 20,400 | 112,000 | 78 K to 112 K (+43.59 %) |
| Aug 05 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and ... | Buy | M | 3.54 | 8,000 | 28,320 | 78,000 | 70 K to 78 K (+11.43 %) |
| Aug 05 2014 | EPZM | Epizyme, Inc. | Gould Robert J | CEO | Option Exercise | M | 0.51 | 30,000 | 15,300 | 657,223 | |
| Aug 05 2014 | EPZM | Epizyme, Inc. | Gould Robert J | CEO | Sell | S | 30.78 | 10,180 | 313,364 | 0 | 10.2 K to 0 (-100.00 %) |
| Aug 05 2014 | EPZM | Epizyme, Inc. | Gould Robert J | CEO | Sell | S | 29.96 | 19,820 | 593,892 | 10,180 | 30 K to 10.2 K (-66.07 %) |
| Aug 05 2014 | EPZM | Epizyme, Inc. | Gould Robert J | CEO | Buy | M | 0.51 | 30,000 | 15,300 | 30,000 | 0 to 30 K |
| Jul 28 2014 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Option Exercise | A | 33.21 | 7,333 | 243,529 | 7,333 | |
| Jul 25 2014 | EPZM | Epizyme, Inc. | SEIDENBERG BETH C | Director | Option Exercise | A | 33.21 | 7,333 | 243,529 | 7,333 | |
| Jul 25 2014 | EPZM | Epizyme, Inc. | POPS RICHARD F | Director | Option Exercise | A | 33.21 | 7,333 | 243,529 | 7,333 | |
| Jul 25 2014 | EPZM | Epizyme, Inc. | GOLDFISCHER CARL | Director | Option Exercise | A | 33.21 | 7,333 | 243,529 | 7,333 | |
| Jul 17 2014 | EPZM | Epizyme, Inc. | Hedrick Eric | Chief Medical Offic ... | Option Exercise | M | 2.19 | 2,000 | 4,380 | 282,500 | |
| Jul 17 2014 | EPZM | Epizyme, Inc. | Hedrick Eric | Chief Medical Offic ... | Sell | S | 31.35 | 2,000 | 62,700 | 0 | 2 K to 0 (-100.00 %) |
| Jul 17 2014 | EPZM | Epizyme, Inc. | Hedrick Eric | Chief Medical Offic ... | Buy | M | 2.19 | 2,000 | 4,380 | 2,000 | 0 to 2 K |
| Jul 09 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and ... | Option Exercise | M | 0.51 | 32,000 | 16,320 | 193,459 | |
| Jul 09 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and ... | Option Exercise | M | 0.60 | 4,000 | 2,400 | 104,819 | |
| Jul 09 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and ... | Option Exercise | M | 3.54 | 6,000 | 21,240 | 202,833 | |
| Jul 09 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and ... | Sell | S | 33.55 | 6,446 | 216,258 | 70,000 | 76.4 K to 70 K (-8.43 %) |
| Jul 09 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and ... | Sell | S | 32.52 | 23,554 | 765,903 | 76,446 | 100 K to 76.4 K (-23.55 %) |
| Jul 09 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and ... | Buy | M | 0.51 | 32,000 | 16,320 | 100,000 | 68 K to 100 K (+47.06 %) |
| Jul 09 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and ... | Buy | M | 0.60 | 4,000 | 2,400 | 68,000 | 64 K to 68 K (+6.25 %) |
| Jul 09 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and ... | Buy | M | 3.54 | 6,000 | 21,240 | 64,000 | 58 K to 64 K (+10.34 %) |
| Jul 03 2014 | EPZM | Epizyme, Inc. | Gould Robert J | CEO | Option Exercise | M | 0.51 | 30,000 | 15,300 | 687,223 | |
| Jul 03 2014 | EPZM | Epizyme, Inc. | Gould Robert J | CEO | Sell | S | 31.89 | 400 | 12,756 | 0 | 400 to 0 (-100.00 %) |
| Jul 03 2014 | EPZM | Epizyme, Inc. | Gould Robert J | CEO | Sell | S | 31.52 | 29,600 | 933,039 | 400 | 30 K to 400 (-98.67 %) |
| Jul 03 2014 | EPZM | Epizyme, Inc. | Gould Robert J | CEO | Buy | M | 0.51 | 30,000 | 15,300 | 30,000 | 0 to 30 K |
| Jun 25 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Option Exercise | M | 0.60 | 13,450 | 8,070 | 96,314 | |
| Jun 25 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Option Exercise | M | 0.51 | 6,550 | 3,341 | 1,250 | |
| Jun 25 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Sell | S | 28.88 | 5,184 | 149,715 | 5,305 | 10.5 K to 5.3 K (-49.42 %) |
| Jun 25 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Sell | S | 28.26 | 14,816 | 418,697 | 10,489 | 25.3 K to 10.5 K (-58.55 %) |
| Jun 25 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Buy | M | 0.60 | 13,450 | 8,070 | 25,305 | 11.9 K to 25.3 K (+113.45 %) |
| Jun 25 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Buy | M | 0.51 | 6,550 | 3,341 | 11,855 | 5.3 K to 11.9 K (+123.47 %) |
| Jun 18 2014 | EPZM | Epizyme, Inc. | Hedrick Eric | Chief Medical Offic ... | Option Exercise | M | 2.19 | 2,000 | 4,380 | 284,500 | |
| Jun 18 2014 | EPZM | Epizyme, Inc. | Hedrick Eric | Chief Medical Offic ... | Sell | S | 26.42 | 2,000 | 52,840 | 0 | 2 K to 0 (-100.00 %) |
| Jun 18 2014 | EPZM | Epizyme, Inc. | Hedrick Eric | Chief Medical Offic ... | Buy | M | 2.19 | 2,000 | 4,380 | 2,000 | 0 to 2 K |
| Jun 18 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Sell | S | 26.38 | 12,756 | 336,540 | 5,525 | 18.3 K to 5.5 K (-69.78 %) |
| Jun 18 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Sell | S | 26.38 | 12,256 | 323,349 | 5,305 | 17.6 K to 5.3 K (-69.79 %) |
| Jun 11 2014 | EPZM | Epizyme, Inc. | Allen Andrew R | Director | Option Exercise | A | 24.29 | 17,666 | 429,107 | 17,666 | |
| Jun 04 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Option Exercise | M | 0.51 | 38,400 | 19,584 | 7,800 | |
| Jun 04 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Sell | S | 23.21 | 3,100 | 71,950 | 17,561 | 20.7 K to 17.6 K (-15.00 %) |
| Jun 04 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Sell | S | 22.21 | 35,300 | 784,115 | 20,661 | 56 K to 20.7 K (-63.08 %) |
| Jun 04 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Buy | M | 0.51 | 38,400 | 19,584 | 55,961 | 17.6 K to 56 K (+218.67 %) |
| Jun 04 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and ... | Option Exercise | M | 0.51 | 27,000 | 13,770 | 225,459 | |
| Jun 04 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and ... | Option Exercise | M | 3.54 | 15,000 | 53,100 | 208,833 | |
| Jun 04 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and ... | Sell | S | 23.36 | 1,264 | 29,529 | 58,000 | 59.3 K to 58 K (-2.13 %) |
| Jun 04 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and ... | Sell | S | 22.14 | 28,736 | 636,341 | 59,264 | 88 K to 59.3 K (-32.65 %) |
| Jun 04 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and ... | Buy | M | 0.51 | 27,000 | 13,770 | 88,000 | 61 K to 88 K (+44.26 %) |
| Jun 04 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and ... | Buy | M | 3.54 | 15,000 | 53,100 | 61,000 | 46 K to 61 K (+32.61 %) |
| Jun 04 2014 | EPZM | Epizyme, Inc. | Gould Robert J | CEO | Option Exercise | M | 0.51 | 30,000 | 15,300 | 717,223 | |
| Jun 04 2014 | EPZM | Epizyme, Inc. | Gould Robert J | CEO | Sell | S | 23.34 | 1,200 | 28,011 | 0 | 1.2 K to 0 (-100.00 %) |
| Jun 04 2014 | EPZM | Epizyme, Inc. | Gould Robert J | CEO | Sell | S | 22.15 | 28,800 | 638,050 | 1,200 | 30 K to 1.2 K (-96.00 %) |
| Jun 04 2014 | EPZM | Epizyme, Inc. | Gould Robert J | CEO | Buy | M | 0.51 | 30,000 | 15,300 | 30,000 | 0 to 30 K |
| May 21 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Sell | S | 22.28 | 2,550 | 56,804 | 18,281 | 20.8 K to 18.3 K (-12.24 %) |
| May 21 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Sell | S | 22.28 | 2,450 | 54,576 | 17,561 | 20 K to 17.6 K (-12.24 %) |
| May 05 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Sell | S | 21.29 | 5,100 | 108,571 | 20,831 | 25.9 K to 20.8 K (-19.67 %) |
| May 05 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Sell | S | 21.29 | 4,900 | 104,313 | 20,011 | 24.9 K to 20 K (-19.67 %) |
| May 05 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and ... | Option Exercise | M | 0.51 | 5,000 | 2,550 | 252,459 | |
| May 05 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and ... | Option Exercise | M | 3.54 | 37,000 | 130,980 | 223,833 | |
| May 05 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and ... | Sell | S | 21.53 | 30,000 | 645,840 | 46,000 | 76 K to 46 K (-39.47 %) |
| May 05 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and ... | Buy | M | 0.51 | 5,000 | 2,550 | 76,000 | 71 K to 76 K (+7.04 %) |
| May 05 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and ... | Buy | M | 3.54 | 37,000 | 130,980 | 71,000 | 34 K to 71 K (+108.82 %) |
| May 05 2014 | EPZM | Epizyme, Inc. | Gould Robert J | CEO | Option Exercise | M | 0.51 | 30,000 | 15,300 | 747,223 | |
| May 05 2014 | EPZM | Epizyme, Inc. | Gould Robert J | CEO | Sell | S | 22.28 | 1,913 | 42,619 | 0 | 1.9 K to 0 (-100.00 %) |
| May 05 2014 | EPZM | Epizyme, Inc. | Gould Robert J | CEO | Sell | S | 21.89 | 28,087 | 614,819 | 1,913 | 30 K to 1.9 K (-93.62 %) |
| May 05 2014 | EPZM | Epizyme, Inc. | Gould Robert J | CEO | Buy | M | 0.51 | 30,000 | 15,300 | 30,000 | 0 to 30 K |
| Apr 30 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Option Exercise | M | 0.51 | 13,800 | 7,038 | 46,200 | |
| Apr 30 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Sell | S | 20.73 | 13,800 | 286,085 | 24,911 | 38.7 K to 24.9 K (-35.65 %) |
| Apr 30 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Buy | M | 0.51 | 13,800 | 7,038 | 38,711 | 24.9 K to 38.7 K (+55.40 %) |
| Apr 08 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and ... | Option Exercise | M | 0.51 | 35,000 | 17,850 | 257,459 | |
| Apr 08 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and ... | Sell | S | 20.05 | 25,000 | 501,190 | 34,000 | 59 K to 34 K (-42.37 %) |
| Apr 08 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and ... | Buy | M | 0.51 | 35,000 | 17,850 | 59,000 | 24 K to 59 K (+145.83 %) |
| Apr 08 2014 | EPZM | Epizyme, Inc. | Gould Robert J | CEO | Option Exercise | M | 0.51 | 30,000 | 15,300 | 777,223 | |
| Apr 08 2014 | EPZM | Epizyme, Inc. | Gould Robert J | CEO | Sell | S | 20.22 | 30,000 | 606,738 | 0 | 30 K to 0 (-100.00 %) |
| Apr 08 2014 | EPZM | Epizyme, Inc. | Gould Robert J | CEO | Buy | M | 0.51 | 30,000 | 15,300 | 30,000 | 0 to 30 K |
| Feb 12 2014 | EPZM | Epizyme, Inc. | KPCB XIII Associates, LLC | 10% Owner | Sell | S | 27.64 | 388,584 | 10,740,967 | 3,838,167 | 4.2 M to 3.8 M (-9.19 %) |
| Feb 12 2014 | EPZM | Epizyme, Inc. | Hedrick Eric | Chief Medical Offic ... | Option Exercise | M | 2.19 | 13,500 | 29,565 | 286,500 | |
| Feb 12 2014 | EPZM | Epizyme, Inc. | Hedrick Eric | Chief Medical Offic ... | Sell | S | 29.25 | 13,500 | 394,875 | 0 | 13.5 K to 0 (-100.00 %) |
| Feb 12 2014 | EPZM | Epizyme, Inc. | Hedrick Eric | Chief Medical Offic ... | Buy | M | 2.19 | 13,500 | 29,565 | 13,500 | 0 to 13.5 K |
| Feb 12 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Sell | S | 29.25 | 19,179 | 560,986 | 24,911 | 44.1 K to 24.9 K (-43.50 %) |
| Feb 12 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and ... | Option Exercise | M | 0.51 | 20,000 | 10,200 | 292,459 | |
| Feb 12 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and ... | Option Exercise | M | 3.54 | 50,000 | 177,000 | 260,833 | |
| Feb 12 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and ... | Sell | S | 29.25 | 50,000 | 1,462,500 | 24,000 | 74 K to 24 K (-67.57 %) |
| Feb 12 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and ... | Buy | M | 0.51 | 20,000 | 10,200 | 74,000 | 54 K to 74 K (+37.04 %) |
| Feb 12 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and ... | Buy | M | 3.54 | 50,000 | 177,000 | 54,000 | 4 K to 54 K (+1,250.00 %) |
| Feb 12 2014 | EPZM | Epizyme, Inc. | GOLDFISCHER CARL | Director | Sell | S | 29.25 | 8,727 | 255,265 | 3,192,062 | 3.2 M to 3.2 M (-0.27 %) |
| Feb 12 2014 | EPZM | Epizyme, Inc. | GOLDFISCHER CARL | Director | Sell | S | 29.25 | 457,940 | 13,394,745 | 3,200,789 | 3.7 M to 3.2 M (-12.52 %) |
| Feb 12 2014 | EPZM | Epizyme, Inc. | Gould Robert J | CEO | Option Exercise | M | 0.51 | 60,000 | 30,600 | 807,223 | |
| Feb 12 2014 | EPZM | Epizyme, Inc. | Gould Robert J | CEO | Sell | S | 29.25 | 60,000 | 1,755,000 | 0 | 60 K to 0 (-100.00 %) |
| Feb 12 2014 | EPZM | Epizyme, Inc. | Gould Robert J | CEO | Buy | M | 0.51 | 60,000 | 30,600 | 60,000 | 0 to 60 K |
| Feb 12 2014 | EPZM | Epizyme, Inc. | BAY CITY CAPITAL LLC | 10% Owner | Sell | S | 29.25 | 8,727 | 255,265 | 3,192,062 | 3.2 M to 3.2 M (-0.27 %) |
| Feb 12 2014 | EPZM | Epizyme, Inc. | BAY CITY CAPITAL LLC | 10% Owner | Sell | S | 29.25 | 457,940 | 13,394,745 | 3,200,789 | 3.7 M to 3.2 M (-12.52 %) |
| Feb 12 2014 | EPZM | Epizyme, Inc. | SEIDENBERG BETH C | Director | Sell | S | 27.64 | 388,584 | 10,740,967 | 3,838,167 | 4.2 M to 3.8 M (-9.19 %) |
| Feb 11 2014 | EPZM | Epizyme, Inc. | Celgene European Investment Co ... | 10% Owner | Buy | P | 29.25 | 340,000 | 9,945,000 | 3,674,640 | 3.3 M to 3.7 M (+10.20 %) |
| Feb 11 2014 | EPZM | Epizyme, Inc. | MPM BioVentures IV QP LP | 10% Owner | Sell | S | 29.25 | 466,666 | 13,649,981 | 2,413,819 | 2.9 M to 2.4 M (-16.20 %) |
| Feb 11 2014 | EPZM | Epizyme, Inc. | EVNIN LUKE | 10% Owner | Sell | S | 29.25 | 466,666 | 13,649,981 | 2,413,819 | 2.9 M to 2.4 M (-16.20 %) |
| Jan 30 2014 | EPZM | Epizyme, Inc. | Hedrick Eric | Chief Medical Offic ... | Option Exercise | A | 31.20 | 21,082 | 657,758 | 21,082 | |
| Jan 30 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Option Exercise | A | 31.20 | 27,406 | 855,067 | 27,406 |